

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 9.58212139 |
| 2 | ATP synthesis coupled proton transport (GO:0015986) | 9.58212139 |
| 3 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 8.50971468 |
| 4 | * respiratory electron transport chain (GO:0022904) | 8.23391207 |
| 5 | * electron transport chain (GO:0022900) | 8.03297853 |
| 6 | oxidative phosphorylation (GO:0006119) | 6.87380012 |
| 7 | tricarboxylic acid cycle (GO:0006099) | 6.46768255 |
| 8 | ATP biosynthetic process (GO:0006754) | 5.76823638 |
| 9 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 5.59703649 |
| 10 | translational initiation (GO:0006413) | 5.39608189 |
| 11 | NADH metabolic process (GO:0006734) | 5.27966254 |
| 12 | maturation of SSU-rRNA (GO:0030490) | 5.15811310 |
| 13 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 5.04059420 |
| 14 | chaperone-mediated protein transport (GO:0072321) | 5.01845030 |
| 15 | ribosomal large subunit biogenesis (GO:0042273) | 5.00932313 |
| 16 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 4.98022688 |
| 17 | * hydrogen ion transmembrane transport (GO:1902600) | 4.86832861 |
| 18 | protein complex disassembly (GO:0043241) | 4.86495919 |
| 19 | inner mitochondrial membrane organization (GO:0007007) | 4.76156840 |
| 20 | protein complex biogenesis (GO:0070271) | 4.72783947 |
| 21 | macromolecular complex disassembly (GO:0032984) | 4.62420702 |
| 22 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.61883669 |
| 23 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.61883669 |
| 24 | NADH dehydrogenase complex assembly (GO:0010257) | 4.61883669 |
| 25 | protein targeting to membrane (GO:0006612) | 4.58724097 |
| 26 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 4.51240066 |
| 27 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.46588589 |
| 28 | aerobic respiration (GO:0009060) | 4.26582830 |
| 29 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.19283911 |
| 30 | sarcomere organization (GO:0045214) | 4.18787698 |
| 31 | succinate metabolic process (GO:0006105) | 4.18670440 |
| 32 | * proton transport (GO:0015992) | 4.18374011 |
| 33 | * hydrogen transport (GO:0006818) | 4.12126793 |
| 34 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.00549377 |
| 35 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.98457326 |
| 36 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.96005323 |
| 37 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.89593060 |
| 38 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.86940284 |
| 39 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.86940284 |
| 40 | protein neddylation (GO:0045116) | 3.83082035 |
| 41 | viral transcription (GO:0019083) | 3.80318510 |
| 42 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.78361854 |
| 43 | regulation of mitochondrial translation (GO:0070129) | 3.78084913 |
| 44 | quinone biosynthetic process (GO:1901663) | 3.78021800 |
| 45 | ubiquinone biosynthetic process (GO:0006744) | 3.78021800 |
| 46 | regulation of oxidative phosphorylation (GO:0002082) | 3.77954086 |
| 47 | cellular component biogenesis (GO:0044085) | 3.76884592 |
| 48 | regulation of coenzyme metabolic process (GO:0051196) | 3.75454846 |
| 49 | regulation of cofactor metabolic process (GO:0051193) | 3.75454846 |
| 50 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.73390793 |
| 51 | mitochondrial transport (GO:0006839) | 3.73162148 |
| 52 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.69219371 |
| 53 | negative regulation of ligase activity (GO:0051352) | 3.68327684 |
| 54 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.68327684 |
| 55 | oxaloacetate metabolic process (GO:0006107) | 3.67590176 |
| 56 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.64693155 |
| 57 | termination of RNA polymerase III transcription (GO:0006386) | 3.64457131 |
| 58 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.64457131 |
| 59 | translational termination (GO:0006415) | 3.61598924 |
| 60 | mRNA catabolic process (GO:0006402) | 3.58516491 |
| 61 | regulation of cellular respiration (GO:0043457) | 3.57250486 |
| 62 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.54165262 |
| 63 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.53853525 |
| 64 | heart process (GO:0003015) | 3.52986914 |
| 65 | heart contraction (GO:0060047) | 3.52986914 |
| 66 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.51824165 |
| 67 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.51824165 |
| 68 | ribosomal small subunit assembly (GO:0000028) | 3.51511884 |
| 69 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.50141258 |
| 70 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.50141258 |
| 71 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.50141258 |
| 72 | actin-myosin filament sliding (GO:0033275) | 3.43197698 |
| 73 | muscle filament sliding (GO:0030049) | 3.43197698 |
| 74 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.39921861 |
| 75 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.39921861 |
| 76 | establishment of protein localization to membrane (GO:0090150) | 3.39802616 |
| 77 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.39117702 |
| 78 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.39117702 |
| 79 | protein targeting to mitochondrion (GO:0006626) | 3.35367351 |
| 80 | formation of translation preinitiation complex (GO:0001731) | 3.35297149 |
| 81 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.35269237 |
| 82 | * generation of precursor metabolites and energy (GO:0006091) | 3.35055097 |
| 83 | ubiquinone metabolic process (GO:0006743) | 3.34924533 |
| 84 | translational elongation (GO:0006414) | 3.34533840 |
| 85 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.33148059 |
| 86 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.32958856 |
| 87 | ribosomal small subunit biogenesis (GO:0042274) | 3.32878163 |
| 88 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.32697497 |
| 89 | establishment of protein localization to mitochondrion (GO:0072655) | 3.31901573 |
| 90 | cellular respiration (GO:0045333) | 3.31378916 |
| 91 | intracellular protein transmembrane import (GO:0044743) | 3.30760615 |
| 92 | protein targeting (GO:0006605) | 3.28115100 |
| 93 | protein localization to mitochondrion (GO:0070585) | 3.26866755 |
| 94 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.25850845 |
| 95 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.24902294 |
| 96 | RNA catabolic process (GO:0006401) | 3.24479226 |
| 97 | cardiac muscle contraction (GO:0060048) | 3.23546224 |
| 98 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.22753438 |
| 99 | cotranslational protein targeting to membrane (GO:0006613) | 3.22732349 |
| 100 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.22058350 |
| 101 | respiratory chain complex IV assembly (GO:0008535) | 3.20997368 |
| 102 | purine nucleoside biosynthetic process (GO:0042451) | 3.20681216 |
| 103 | purine ribonucleoside biosynthetic process (GO:0046129) | 3.20681216 |
| 104 | sequestering of actin monomers (GO:0042989) | 3.20109037 |
| 105 | protein targeting to ER (GO:0045047) | 3.19177536 |
| 106 | cytochrome complex assembly (GO:0017004) | 3.17360651 |
| 107 | ribonucleoside monophosphate biosynthetic process (GO:0009156) | 3.17092009 |
| 108 | aspartate family amino acid catabolic process (GO:0009068) | 3.11873216 |
| 109 | regulation of relaxation of muscle (GO:1901077) | 3.10621499 |
| 110 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.10118261 |
| 111 | cardiac myofibril assembly (GO:0055003) | 3.09827086 |
| 112 | branched-chain amino acid catabolic process (GO:0009083) | 3.08792064 |
| 113 | protein localization to endoplasmic reticulum (GO:0070972) | 3.08147610 |
| 114 | GTP biosynthetic process (GO:0006183) | 3.07149136 |
| 115 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.06911743 |
| 116 | positive regulation of ligase activity (GO:0051351) | 3.06814143 |
| 117 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.05307186 |
| 118 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.00770542 |
| 119 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.00720025 |
| 120 | nucleoside monophosphate biosynthetic process (GO:0009124) | 2.98455488 |
| 121 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.98320366 |
| 122 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.97186779 |
| 123 | cullin deneddylation (GO:0010388) | 2.95631102 |
| 124 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.95519598 |
| 125 | cellular protein complex disassembly (GO:0043624) | 2.95188428 |
| 126 | regulation of cell communication by electrical coupling (GO:0010649) | 2.94825800 |
| 127 | regulation of cellular amine metabolic process (GO:0033238) | 2.93851043 |
| 128 | fatty acid beta-oxidation (GO:0006635) | 2.93695847 |
| 129 | rRNA modification (GO:0000154) | 2.93371377 |
| 130 | aldehyde catabolic process (GO:0046185) | 2.92352261 |
| 131 | viral life cycle (GO:0019058) | 2.89243359 |
| 132 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.88879936 |
| 133 | 2-oxoglutarate metabolic process (GO:0006103) | 2.87821156 |
| 134 | mitochondrial fusion (GO:0008053) | 2.87255741 |
| 135 | tricarboxylic acid metabolic process (GO:0072350) | 2.85088857 |
| 136 | lysine catabolic process (GO:0006554) | 2.84453615 |
| 137 | lysine metabolic process (GO:0006553) | 2.84453615 |
| 138 | proteasome assembly (GO:0043248) | 2.83751457 |
| 139 | translation (GO:0006412) | 2.81775066 |
| 140 | myofibril assembly (GO:0030239) | 2.80127674 |
| 141 | regulation of actin filament-based movement (GO:1903115) | 2.77850052 |
| 142 | ribonucleoside biosynthetic process (GO:0042455) | 2.76772129 |
| 143 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 10.3333803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.58783883 |
| 2 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.31888542 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.25250231 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.91805632 |
| 5 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.56625217 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.47422552 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.32935178 |
| 8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.24930720 |
| 9 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.17762683 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.16138913 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.12725705 |
| 12 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.12125303 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.99421354 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.91045530 |
| 15 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.54458056 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.53308586 |
| 17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.47303318 |
| 18 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.43544213 |
| 19 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.38220853 |
| 20 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.36004772 |
| 21 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.35500215 |
| 22 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.26313452 |
| 23 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.25388908 |
| 24 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.19527048 |
| 25 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.17587946 |
| 26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.07483339 |
| 27 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.01253990 |
| 28 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.95908426 |
| 29 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.92664610 |
| 30 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.87213491 |
| 31 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.84380741 |
| 32 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.82843025 |
| 33 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.74095821 |
| 34 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.69347510 |
| 35 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.68200533 |
| 36 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.64500361 |
| 37 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.60763474 |
| 38 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.54733671 |
| 39 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.52994362 |
| 40 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.51691240 |
| 41 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.51289175 |
| 42 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.42472281 |
| 43 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.42226448 |
| 44 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.41012498 |
| 45 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.35980987 |
| 46 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.35681185 |
| 47 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.34419826 |
| 48 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.33586028 |
| 49 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.32536616 |
| 50 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29603185 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25847215 |
| 52 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.24864362 |
| 53 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.24710075 |
| 54 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24508264 |
| 55 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.24438927 |
| 56 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.24032255 |
| 57 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.23489338 |
| 58 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.22744769 |
| 59 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.20958234 |
| 60 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.20447290 |
| 61 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.20238811 |
| 62 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.19590345 |
| 63 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.19530711 |
| 64 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.17455235 |
| 65 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.16731821 |
| 66 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.15727225 |
| 67 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.13815882 |
| 68 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.13622958 |
| 69 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13188118 |
| 70 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.12656069 |
| 71 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11910452 |
| 72 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.11299290 |
| 73 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.08621066 |
| 74 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.08272316 |
| 75 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.07055307 |
| 76 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.03489041 |
| 77 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03065287 |
| 78 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.01988519 |
| 79 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01888003 |
| 80 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.98132606 |
| 81 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97725681 |
| 82 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.97348356 |
| 83 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.96743225 |
| 84 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96164734 |
| 85 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.94800411 |
| 86 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94328406 |
| 87 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.93916853 |
| 88 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93488401 |
| 89 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.92573609 |
| 90 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.91956388 |
| 91 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.91802399 |
| 92 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91360830 |
| 93 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.91305177 |
| 94 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.91156473 |
| 95 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.90455027 |
| 96 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.88113593 |
| 97 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.87922345 |
| 98 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.87558535 |
| 99 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.86949492 |
| 100 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.86938197 |
| 101 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.85068581 |
| 102 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.84586939 |
| 103 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.84429438 |
| 104 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.83144621 |
| 105 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.82935435 |
| 106 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.82895081 |
| 107 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.82884964 |
| 108 | P68_20966046_ChIP-Seq_HELA_Human | 0.82584280 |
| 109 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.82533483 |
| 110 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.81102861 |
| 111 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.80883081 |
| 112 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.80706498 |
| 113 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.80193454 |
| 114 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79979402 |
| 115 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.79578527 |
| 116 | SA1_27219007_Chip-Seq_Bcells_Human | 0.79440478 |
| 117 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.79388985 |
| 118 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78606607 |
| 119 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.78100942 |
| 120 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.77569783 |
| 121 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.76620903 |
| 122 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.75547807 |
| 123 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73869939 |
| 124 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72290248 |
| 125 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.70749022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.70479924 |
| 2 | MP0003646_muscle_fatigue | 4.63493022 |
| 3 | MP0000751_myopathy | 4.07388521 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.91712843 |
| 5 | MP0006036_abnormal_mitochondrial_physio | 3.81330468 |
| 6 | MP0004215_abnormal_myocardial_fiber | 3.72932472 |
| 7 | MP0000749_muscle_degeneration | 3.24652138 |
| 8 | MP0005330_cardiomyopathy | 3.18005464 |
| 9 | MP0004036_abnormal_muscle_relaxation | 3.17406283 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 3.04196312 |
| 11 | MP0000372_irregular_coat_pigmentation | 2.64895217 |
| 12 | MP0006035_abnormal_mitochondrial_morpho | 2.62503584 |
| 13 | MP0003137_abnormal_impulse_conducting | 2.37048674 |
| 14 | MP0001529_abnormal_vocalization | 2.34968407 |
| 15 | MP0002972_abnormal_cardiac_muscle | 2.32255983 |
| 16 | MP0008775_abnormal_heart_ventricle | 2.28267289 |
| 17 | MP0004043_abnormal_pH_regulation | 2.17004446 |
| 18 | MP0003186_abnormal_redox_activity | 2.15064535 |
| 19 | MP0000750_abnormal_muscle_regeneration | 2.11318409 |
| 20 | MP0004087_abnormal_muscle_fiber | 2.01153438 |
| 21 | MP0004130_abnormal_muscle_cell | 1.94350716 |
| 22 | MP0005620_abnormal_muscle_contractility | 1.93816548 |
| 23 | MP0001544_abnormal_cardiovascular_syste | 1.90474205 |
| 24 | MP0005385_cardiovascular_system_phenoty | 1.90474205 |
| 25 | MP0003123_paternal_imprinting | 1.81671436 |
| 26 | MP0003011_delayed_dark_adaptation | 1.81519637 |
| 27 | MP0002106_abnormal_muscle_physiology | 1.79699969 |
| 28 | MP0002822_catalepsy | 1.78844121 |
| 29 | MP0008995_early_reproductive_senescence | 1.78761674 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.77950505 |
| 31 | MP0008058_abnormal_DNA_repair | 1.72165145 |
| 32 | MP0002269_muscular_atrophy | 1.72159100 |
| 33 | MP0000747_muscle_weakness | 1.68253895 |
| 34 | MP0004957_abnormal_blastocyst_morpholog | 1.66711330 |
| 35 | MP0003136_yellow_coat_color | 1.65999921 |
| 36 | MP0004484_altered_response_of | 1.65586083 |
| 37 | MP0005423_abnormal_somatic_nervous | 1.60024851 |
| 38 | MP0006138_congestive_heart_failure | 1.59803732 |
| 39 | MP0002332_abnormal_exercise_endurance | 1.57521293 |
| 40 | MP0003693_abnormal_embryo_hatching | 1.57195403 |
| 41 | MP0009379_abnormal_foot_pigmentation | 1.56823950 |
| 42 | MP0002938_white_spotting | 1.53735856 |
| 43 | MP0005332_abnormal_amino_acid | 1.52223542 |
| 44 | MP0004270_analgesia | 1.50308635 |
| 45 | MP0004085_abnormal_heartbeat | 1.49095022 |
| 46 | MP0004145_abnormal_muscle_electrophysio | 1.48279041 |
| 47 | MP0004147_increased_porphyrin_level | 1.47691997 |
| 48 | MP0003880_abnormal_central_pattern | 1.42472617 |
| 49 | MP0005266_abnormal_metabolism | 1.42009811 |
| 50 | MP0005369_muscle_phenotype | 1.38872267 |
| 51 | MP0000759_abnormal_skeletal_muscle | 1.37922310 |
| 52 | MP0004142_abnormal_muscle_tone | 1.36744612 |
| 53 | MP0003786_premature_aging | 1.35925133 |
| 54 | MP0001905_abnormal_dopamine_level | 1.34008449 |
| 55 | MP0000013_abnormal_adipose_tissue | 1.32489459 |
| 56 | MP0003195_calcinosis | 1.31138542 |
| 57 | MP0010630_abnormal_cardiac_muscle | 1.29349986 |
| 58 | MP0002277_abnormal_respiratory_mucosa | 1.29248155 |
| 59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.27784464 |
| 60 | MP0001984_abnormal_olfaction | 1.21507231 |
| 61 | MP0002736_abnormal_nociception_after | 1.18845190 |
| 62 | MP0005408_hypopigmentation | 1.18680574 |
| 63 | MP0006276_abnormal_autonomic_nervous | 1.18020292 |
| 64 | MP0004742_abnormal_vestibular_system | 1.16883594 |
| 65 | MP0005535_abnormal_body_temperature | 1.15640749 |
| 66 | MP0005636_abnormal_mineral_homeostasis | 1.15074383 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 1.14451246 |
| 68 | MP0002163_abnormal_gland_morphology | 1.14368792 |
| 69 | MP0005083_abnormal_biliary_tract | 1.13265650 |
| 70 | MP0005165_increased_susceptibility_to | 1.09254318 |
| 71 | MP0005666_abnormal_adipose_tissue | 1.08190158 |
| 72 | MP0002272_abnormal_nervous_system | 1.07920818 |
| 73 | MP0004233_abnormal_muscle_weight | 1.07461475 |
| 74 | MP0009046_muscle_twitch | 1.07437105 |
| 75 | MP0002638_abnormal_pupillary_reflex | 1.06839555 |
| 76 | MP0006072_abnormal_retinal_apoptosis | 1.06706898 |
| 77 | MP0005379_endocrine/exocrine_gland_phen | 1.06698375 |
| 78 | MP0000230_abnormal_systemic_arterial | 1.05677039 |
| 79 | MP0004019_abnormal_vitamin_homeostasis | 1.03019365 |
| 80 | MP0009643_abnormal_urine_homeostasis | 1.01687392 |
| 81 | MP0000343_altered_response_to | 0.99666423 |
| 82 | MP0001986_abnormal_taste_sensitivity | 0.99580848 |
| 83 | MP0005360_urolithiasis | 0.99303691 |
| 84 | MP0005670_abnormal_white_adipose | 0.98603320 |
| 85 | MP0002064_seizures | 0.97406619 |
| 86 | MP0008872_abnormal_physiological_respon | 0.97258179 |
| 87 | MP0005386_behavior/neurological_phenoty | 0.96751987 |
| 88 | MP0004924_abnormal_behavior | 0.96751987 |
| 89 | MP0001440_abnormal_grooming_behavior | 0.95633412 |
| 90 | MP0005451_abnormal_body_composition | 0.94880580 |
| 91 | MP0000358_abnormal_cell_content/ | 0.94738207 |
| 92 | MP0002572_abnormal_emotion/affect_behav | 0.92879461 |
| 93 | MP0006292_abnormal_olfactory_placode | 0.92531774 |
| 94 | MP0009840_abnormal_foam_cell | 0.92305937 |
| 95 | MP0001756_abnormal_urination | 0.92182149 |
| 96 | MP0003718_maternal_effect | 0.92131098 |
| 97 | MP0002132_abnormal_respiratory_system | 0.91917658 |
| 98 | MP0001853_heart_inflammation | 0.91716422 |
| 99 | MP0002095_abnormal_skin_pigmentation | 0.89642764 |
| 100 | MP0001727_abnormal_embryo_implantation | 0.89238129 |
| 101 | MP0005319_abnormal_enzyme/_coenzyme | 0.89084787 |
| 102 | MP0002067_abnormal_sensory_capabilities | 0.88867739 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.88402696 |
| 104 | MP0002909_abnormal_adrenal_gland | 0.88303293 |
| 105 | MP0001968_abnormal_touch/_nociception | 0.87595120 |
| 106 | MP0001970_abnormal_pain_threshold | 0.85948575 |
| 107 | MP0008569_lethality_at_weaning | 0.85304482 |
| 108 | MP0005085_abnormal_gallbladder_physiolo | 0.85124315 |
| 109 | MP0009745_abnormal_behavioral_response | 0.83347399 |
| 110 | MP0002090_abnormal_vision | 0.82831983 |
| 111 | MP0002735_abnormal_chemical_nociception | 0.82744696 |
| 112 | MP0003879_abnormal_hair_cell | 0.82070490 |
| 113 | MP0002127_abnormal_cardiovascular_syste | 0.82031353 |
| 114 | MP0005376_homeostasis/metabolism_phenot | 0.81619530 |
| 115 | MP0001486_abnormal_startle_reflex | 0.81201461 |
| 116 | MP0002063_abnormal_learning/memory/cond | 0.81127246 |
| 117 | MP0001764_abnormal_homeostasis | 0.80846656 |
| 118 | MP0002557_abnormal_social/conspecific_i | 0.80403610 |
| 119 | MP0005551_abnormal_eye_electrophysiolog | 0.80234446 |
| 120 | MP0003787_abnormal_imprinting | 0.78044263 |
| 121 | MP0008004_abnormal_stomach_pH | 0.75948960 |
| 122 | MP0003638_abnormal_response/metabolism_ | 0.75910130 |
| 123 | MP0003122_maternal_imprinting | 0.75528247 |
| 124 | MP0003828_pulmonary_edema | 0.75099209 |
| 125 | MP0002066_abnormal_motor_capabilities/c | 0.74366768 |
| 126 | MP0003329_amyloid_beta_deposits | 0.73629960 |
| 127 | MP0005365_abnormal_bile_salt | 0.72988673 |
| 128 | MP0002876_abnormal_thyroid_physiology | 0.72783933 |
| 129 | MP0003077_abnormal_cell_cycle | 0.72443287 |
| 130 | MP0005410_abnormal_fertilization | 0.71820486 |
| 131 | MP0002734_abnormal_mechanical_nocicepti | 0.71795055 |
| 132 | MP0002139_abnormal_hepatobiliary_system | 0.71144522 |
| 133 | MP0003635_abnormal_synaptic_transmissio | 0.70526541 |
| 134 | MP0008932_abnormal_embryonic_tissue | 0.70315990 |
| 135 | MP0001765_abnormal_ion_homeostasis | 0.69557801 |
| 136 | MP0002733_abnormal_thermal_nociception | 0.68937150 |
| 137 | MP0005084_abnormal_gallbladder_morpholo | 0.67164724 |
| 138 | MP0004859_abnormal_synaptic_plasticity | 0.67126695 |
| 139 | MP0001664_abnormal_digestion | 0.66921711 |
| 140 | MP0001485_abnormal_pinna_reflex | 0.66254748 |
| 141 | MP0004510_myositis | 0.64925413 |
| 142 | MP0008875_abnormal_xenobiotic_pharmacok | 0.64379037 |
| 143 | MP0005375_adipose_tissue_phenotype | 0.62418367 |
| 144 | MP0003878_abnormal_ear_physiology | 0.62159060 |
| 145 | MP0005377_hearing/vestibular/ear_phenot | 0.62159060 |
| 146 | MP0002078_abnormal_glucose_homeostasis | 0.59961958 |
| 147 | MP0005058_abnormal_lysosome_morphology | 0.59411299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 6.91309997 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 6.63822051 |
| 3 | Acute encephalopathy (HP:0006846) | 6.10000141 |
| 4 | Mitochondrial inheritance (HP:0001427) | 6.06393928 |
| 5 | Hepatocellular necrosis (HP:0001404) | 5.82207442 |
| 6 | Hepatic necrosis (HP:0002605) | 5.72024541 |
| 7 | Progressive macrocephaly (HP:0004481) | 5.68912547 |
| 8 | Increased CSF lactate (HP:0002490) | 5.43554092 |
| 9 | Cerebral edema (HP:0002181) | 4.69203426 |
| 10 | Reticulocytopenia (HP:0001896) | 4.59446394 |
| 11 | Macrocytic anemia (HP:0001972) | 4.26003629 |
| 12 | Increased muscle lipid content (HP:0009058) | 4.21817757 |
| 13 | Sudden death (HP:0001699) | 4.21677783 |
| 14 | Lactic acidosis (HP:0003128) | 4.20944374 |
| 15 | Increased intramyocellular lipid droplets (HP:0012240) | 4.19904667 |
| 16 | Increased serum pyruvate (HP:0003542) | 4.19255175 |
| 17 | Abnormality of glycolysis (HP:0004366) | 4.19255175 |
| 18 | Respiratory failure (HP:0002878) | 4.14934171 |
| 19 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.08742791 |
| 20 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.08742791 |
| 21 | Lipid accumulation in hepatocytes (HP:0006561) | 4.05544546 |
| 22 | Increased hepatocellular lipid droplets (HP:0006565) | 3.99633356 |
| 23 | Exercise intolerance (HP:0003546) | 3.92294579 |
| 24 | Palpitations (HP:0001962) | 3.63787937 |
| 25 | Increased serum lactate (HP:0002151) | 3.60847627 |
| 26 | Pheochromocytoma (HP:0002666) | 3.60121755 |
| 27 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.55221624 |
| 28 | Neuroendocrine neoplasm (HP:0100634) | 3.51303434 |
| 29 | Myoglobinuria (HP:0002913) | 3.51128399 |
| 30 | Leukodystrophy (HP:0002415) | 3.32375564 |
| 31 | Ventricular tachycardia (HP:0004756) | 3.20691632 |
| 32 | Calf muscle hypertrophy (HP:0008981) | 3.18191614 |
| 33 | Optic disc pallor (HP:0000543) | 3.14994252 |
| 34 | Renal Fanconi syndrome (HP:0001994) | 3.12595992 |
| 35 | Exercise-induced muscle cramps (HP:0003710) | 3.10157324 |
| 36 | Rhabdomyolysis (HP:0003201) | 3.09893500 |
| 37 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.08691350 |
| 38 | Dicarboxylic aciduria (HP:0003215) | 3.08691350 |
| 39 | Exercise-induced myalgia (HP:0003738) | 3.08529097 |
| 40 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.00715349 |
| 41 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.97202557 |
| 42 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.96016273 |
| 43 | Pallor (HP:0000980) | 2.92984979 |
| 44 | CNS demyelination (HP:0007305) | 2.90451344 |
| 45 | Conjunctival hamartoma (HP:0100780) | 2.89214661 |
| 46 | Lethargy (HP:0001254) | 2.86467478 |
| 47 | Muscle fiber splitting (HP:0003555) | 2.72309903 |
| 48 | Lipoatrophy (HP:0100578) | 2.68948175 |
| 49 | Emotional lability (HP:0000712) | 2.65264993 |
| 50 | 3-Methylglutaconic aciduria (HP:0003535) | 2.64452296 |
| 51 | Ragged-red muscle fibers (HP:0003200) | 2.63866615 |
| 52 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.61284831 |
| 53 | Myotonia (HP:0002486) | 2.59334883 |
| 54 | Myokymia (HP:0002411) | 2.57765192 |
| 55 | Exertional dyspnea (HP:0002875) | 2.54532392 |
| 56 | Atrial fibrillation (HP:0005110) | 2.54245189 |
| 57 | Ketoacidosis (HP:0001993) | 2.49883559 |
| 58 | Syncope (HP:0001279) | 2.49533624 |
| 59 | Supraventricular tachycardia (HP:0004755) | 2.48541260 |
| 60 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.48401487 |
| 61 | Abnormality of alanine metabolism (HP:0010916) | 2.48401487 |
| 62 | Hyperalaninemia (HP:0003348) | 2.48401487 |
| 63 | Glycosuria (HP:0003076) | 2.47978395 |
| 64 | Abnormality of urine glucose concentration (HP:0011016) | 2.47978395 |
| 65 | Generalized aminoaciduria (HP:0002909) | 2.47149201 |
| 66 | Abnormality of the calf musculature (HP:0001430) | 2.44686658 |
| 67 | Supraventricular arrhythmia (HP:0005115) | 2.42312390 |
| 68 | Esophageal neoplasm (HP:0100751) | 2.41773009 |
| 69 | Neoplasm of head and neck (HP:0012288) | 2.41773009 |
| 70 | Respiratory difficulties (HP:0002880) | 2.41744597 |
| 71 | Primary atrial arrhythmia (HP:0001692) | 2.40672228 |
| 72 | Ventricular fibrillation (HP:0001663) | 2.40426344 |
| 73 | Dilated cardiomyopathy (HP:0001644) | 2.38856005 |
| 74 | Cerebral hypomyelination (HP:0006808) | 2.38602360 |
| 75 | Microvesicular hepatic steatosis (HP:0001414) | 2.37494578 |
| 76 | Muscle stiffness (HP:0003552) | 2.37375529 |
| 77 | Abnormal number of erythroid precursors (HP:0012131) | 2.36765805 |
| 78 | Multiple enchondromatosis (HP:0005701) | 2.34405680 |
| 79 | Vomiting (HP:0002013) | 2.34193112 |
| 80 | Prolonged QT interval (HP:0001657) | 2.33936223 |
| 81 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.29946365 |
| 82 | Neoplasm of the adrenal gland (HP:0100631) | 2.24941310 |
| 83 | Methylmalonic aciduria (HP:0012120) | 2.22652005 |
| 84 | Hyperglycinuria (HP:0003108) | 2.21563165 |
| 85 | Hypoglycemic coma (HP:0001325) | 2.18963445 |
| 86 | Cholecystitis (HP:0001082) | 2.18077610 |
| 87 | Abnormal gallbladder physiology (HP:0012438) | 2.18077610 |
| 88 | Type I transferrin isoform profile (HP:0003642) | 2.17496106 |
| 89 | X-linked dominant inheritance (HP:0001423) | 2.16873401 |
| 90 | Nausea (HP:0002018) | 2.13996963 |
| 91 | EMG: myopathic abnormalities (HP:0003458) | 2.08177751 |
| 92 | Gliosis (HP:0002171) | 2.08094010 |
| 93 | Ventricular arrhythmia (HP:0004308) | 2.08021022 |
| 94 | Hyperammonemia (HP:0001987) | 2.07837754 |
| 95 | Ketosis (HP:0001946) | 2.06524656 |
| 96 | Bundle branch block (HP:0011710) | 2.06043743 |
| 97 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.04067834 |
| 98 | Abnormality of renal resorption (HP:0011038) | 2.01892686 |
| 99 | Proximal tubulopathy (HP:0000114) | 2.01815109 |
| 100 | Cerebral hemorrhage (HP:0001342) | 2.00186735 |
| 101 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.00126259 |
| 102 | Aplastic anemia (HP:0001915) | 1.98996602 |
| 103 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.98556096 |
| 104 | Abnormality of the vocal cords (HP:0008777) | 1.94776663 |
| 105 | Metabolic acidosis (HP:0001942) | 1.92741244 |
| 106 | Abnormal urine phosphate concentration (HP:0012599) | 1.92464107 |
| 107 | Hyperphosphaturia (HP:0003109) | 1.91225010 |
| 108 | Abnormality of glycine metabolism (HP:0010895) | 1.89963941 |
| 109 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.89963941 |
| 110 | Abnormality of the anterior horn cell (HP:0006802) | 1.89696452 |
| 111 | Degeneration of anterior horn cells (HP:0002398) | 1.89696452 |
| 112 | Testicular atrophy (HP:0000029) | 1.87900870 |
| 113 | Right ventricular cardiomyopathy (HP:0011663) | 1.87501830 |
| 114 | Oral leukoplakia (HP:0002745) | 1.86007941 |
| 115 | Methylmalonic acidemia (HP:0002912) | 1.83063432 |
| 116 | Blindness (HP:0000618) | 1.81339720 |
| 117 | Poor suck (HP:0002033) | 1.80257880 |
| 118 | CNS hypomyelination (HP:0003429) | 1.78301854 |
| 119 | Hyperglycinemia (HP:0002154) | 1.71864642 |
| 120 | Renal tubular dysfunction (HP:0000124) | 1.70235929 |
| 121 | Pancytopenia (HP:0001876) | 1.68367917 |
| 122 | Dysphonia (HP:0001618) | 1.65264492 |
| 123 | Congenital, generalized hypertrichosis (HP:0004540) | 1.64938720 |
| 124 | Abnormality of reticulocytes (HP:0004312) | 1.64208943 |
| 125 | Gout (HP:0001997) | 1.63039878 |
| 126 | Progressive muscle weakness (HP:0003323) | 1.59850362 |
| 127 | Unsteady gait (HP:0002317) | 1.59641675 |
| 128 | Opisthotonus (HP:0002179) | 1.57269278 |
| 129 | Limb dystonia (HP:0002451) | 1.56564834 |
| 130 | Concave nail (HP:0001598) | 1.55645423 |
| 131 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.54845836 |
| 132 | Abnormal protein glycosylation (HP:0012346) | 1.54845836 |
| 133 | Abnormal glycosylation (HP:0012345) | 1.54845836 |
| 134 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.54845836 |
| 135 | Sparse eyelashes (HP:0000653) | 1.52824577 |
| 136 | Abnormality of serum amino acid levels (HP:0003112) | 1.52657352 |
| 137 | Progressive microcephaly (HP:0000253) | 1.50465468 |
| 138 | Focal motor seizures (HP:0011153) | 1.49664174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.52439132 |
| 2 | MYLK | 3.82811958 |
| 3 | NME2 | 3.61989534 |
| 4 | BCKDK | 3.59721682 |
| 5 | PDK3 | 2.89470202 |
| 6 | PDK4 | 2.89470202 |
| 7 | LMTK2 | 2.86986704 |
| 8 | OBSCN | 2.85967864 |
| 9 | NME1 | 2.84734941 |
| 10 | NEK1 | 2.78854436 |
| 11 | ARAF | 2.78450954 |
| 12 | MAP3K12 | 2.69005832 |
| 13 | WNK4 | 2.31276267 |
| 14 | LIMK1 | 2.15874879 |
| 15 | PHKG1 | 2.13647868 |
| 16 | PHKG2 | 2.13647868 |
| 17 | TTN | 2.00153760 |
| 18 | STK16 | 1.93421940 |
| 19 | TESK2 | 1.86573604 |
| 20 | PDK2 | 1.86296629 |
| 21 | STK39 | 1.76006159 |
| 22 | PINK1 | 1.71351940 |
| 23 | ILK | 1.64656776 |
| 24 | DAPK3 | 1.63034941 |
| 25 | BUB1 | 1.62562197 |
| 26 | MUSK | 1.57712169 |
| 27 | PBK | 1.56878232 |
| 28 | TESK1 | 1.56655469 |
| 29 | MAP3K11 | 1.55405448 |
| 30 | OXSR1 | 1.54460497 |
| 31 | EIF2AK1 | 1.53880722 |
| 32 | PIM2 | 1.52381513 |
| 33 | PASK | 1.46033616 |
| 34 | CDK19 | 1.34630718 |
| 35 | MST4 | 1.29861866 |
| 36 | GRK7 | 1.18966202 |
| 37 | PIK3CA | 1.18845899 |
| 38 | GRK5 | 1.17822827 |
| 39 | CDC7 | 1.14307740 |
| 40 | PKN2 | 1.11685650 |
| 41 | CAMK2D | 1.11002870 |
| 42 | WNK3 | 1.09052668 |
| 43 | SRPK1 | 1.07570162 |
| 44 | ABL2 | 1.04860768 |
| 45 | MAPKAPK3 | 1.04696177 |
| 46 | BRAF | 1.03360534 |
| 47 | TLK1 | 1.01125760 |
| 48 | LRRK2 | 0.94764163 |
| 49 | KDR | 0.93055386 |
| 50 | CCNB1 | 0.90375499 |
| 51 | CAMK2G | 0.86015899 |
| 52 | PTK2B | 0.84690980 |
| 53 | BCR | 0.80023076 |
| 54 | CSNK2A2 | 0.79817897 |
| 55 | WEE1 | 0.79383059 |
| 56 | VRK1 | 0.76400893 |
| 57 | TRIB3 | 0.76103466 |
| 58 | MAP4K2 | 0.75545287 |
| 59 | DAPK1 | 0.74329859 |
| 60 | ROCK2 | 0.70686036 |
| 61 | PAK3 | 0.70478022 |
| 62 | TIE1 | 0.68511077 |
| 63 | MINK1 | 0.66925422 |
| 64 | STK4 | 0.65503494 |
| 65 | KSR2 | 0.65162478 |
| 66 | PLK3 | 0.63662689 |
| 67 | CAMK2A | 0.62935626 |
| 68 | AURKB | 0.62280935 |
| 69 | TTK | 0.61525272 |
| 70 | CSNK1G3 | 0.61085737 |
| 71 | UHMK1 | 0.60277765 |
| 72 | CAMK2B | 0.59747780 |
| 73 | RPS6KA5 | 0.59744176 |
| 74 | EPHB2 | 0.58613561 |
| 75 | BRSK1 | 0.57810472 |
| 76 | STK24 | 0.57149529 |
| 77 | PRKCI | 0.55538858 |
| 78 | EIF2AK3 | 0.54657287 |
| 79 | ROCK1 | 0.54003142 |
| 80 | STK38L | 0.52982608 |
| 81 | MST1R | 0.52951483 |
| 82 | RAF1 | 0.52941122 |
| 83 | DMPK | 0.52192301 |
| 84 | PLK1 | 0.50121993 |
| 85 | MAP2K1 | 0.49856242 |
| 86 | TRIM28 | 0.48173038 |
| 87 | RPS6KB2 | 0.47394347 |
| 88 | PAK1 | 0.47359356 |
| 89 | MAP2K7 | 0.47043553 |
| 90 | PRKACA | 0.46822527 |
| 91 | CSNK1G2 | 0.45723976 |
| 92 | ADRBK1 | 0.43533237 |
| 93 | AURKA | 0.43226314 |
| 94 | MAP2K2 | 0.43123372 |
| 95 | TSSK6 | 0.43038916 |
| 96 | ALK | 0.43006878 |
| 97 | CDK14 | 0.42755010 |
| 98 | GRK1 | 0.41196847 |
| 99 | PAK4 | 0.40252037 |
| 100 | PRKD1 | 0.39007663 |
| 101 | PAK6 | 0.38266111 |
| 102 | FLT3 | 0.37968672 |
| 103 | CAMKK2 | 0.37656034 |
| 104 | NTRK3 | 0.36933670 |
| 105 | CSNK1E | 0.36357488 |
| 106 | AKT2 | 0.36177034 |
| 107 | ADRBK2 | 0.34916498 |
| 108 | CDK18 | 0.34893084 |
| 109 | PDPK1 | 0.34860821 |
| 110 | CAMK1 | 0.34807848 |
| 111 | PRKCA | 0.34094736 |
| 112 | ZAK | 0.33948096 |
| 113 | DAPK2 | 0.33474289 |
| 114 | CSNK1G1 | 0.33090287 |
| 115 | CDK8 | 0.32833340 |
| 116 | CDK15 | 0.32732559 |
| 117 | MAP3K9 | 0.32730912 |
| 118 | SCYL2 | 0.32636079 |
| 119 | CDK11A | 0.32286139 |
| 120 | MAPK12 | 0.31747913 |
| 121 | INSRR | 0.30938203 |
| 122 | CSNK1A1 | 0.30517164 |
| 123 | DYRK2 | 0.30265316 |
| 124 | PRKACG | 0.29798817 |
| 125 | PRKG2 | 0.28838753 |
| 126 | MAP2K6 | 0.28189300 |
| 127 | PRKACB | 0.27672257 |
| 128 | PRKCE | 0.27597291 |
| 129 | MAPKAPK5 | 0.27338051 |
| 130 | PIK3CG | 0.26824793 |
| 131 | PRKCD | 0.25785875 |
| 132 | PRKCG | 0.25156838 |
| 133 | MAP2K4 | 0.24107687 |
| 134 | PLK2 | 0.23843468 |
| 135 | CSNK2A1 | 0.23821122 |
| 136 | EPHA4 | 0.22984637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 5.89543184 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 5.29425336 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.67099878 |
| 4 | Alzheimers disease_Homo sapiens_hsa05010 | 3.77268653 |
| 5 | Huntingtons disease_Homo sapiens_hsa05016 | 3.53909204 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.31313476 |
| 7 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 3.28339072 |
| 8 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.27567479 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 3.00192579 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.75073650 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.51895250 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.26932117 |
| 13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.18553423 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.02864521 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.84977312 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.84318796 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.82497406 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.79583250 |
| 19 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.67530053 |
| 20 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.52999601 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.52778654 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.43157841 |
| 23 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.32679045 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.25399338 |
| 25 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19701364 |
| 26 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.17572230 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16376896 |
| 28 | RNA polymerase_Homo sapiens_hsa03020 | 1.14454632 |
| 29 | Base excision repair_Homo sapiens_hsa03410 | 1.06374936 |
| 30 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.97529809 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 0.95227359 |
| 32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.93365945 |
| 33 | Protein export_Homo sapiens_hsa03060 | 0.91473903 |
| 34 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.87868850 |
| 35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.87035627 |
| 36 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.86201789 |
| 37 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.83679041 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.80884078 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.80315700 |
| 40 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.80119150 |
| 41 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.79326859 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78620929 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76892725 |
| 44 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.75900672 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 0.74643717 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73912991 |
| 47 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73704012 |
| 48 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.72835593 |
| 49 | RNA degradation_Homo sapiens_hsa03018 | 0.72799554 |
| 50 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71454983 |
| 51 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70826719 |
| 52 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.69760469 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67565361 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.66288165 |
| 55 | RNA transport_Homo sapiens_hsa03013 | 0.63153268 |
| 56 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63132686 |
| 57 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.57774810 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55947611 |
| 59 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.55409138 |
| 60 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.53101692 |
| 61 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.51351713 |
| 62 | Basal transcription factors_Homo sapiens_hsa03022 | 0.50686555 |
| 63 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.48646323 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44301578 |
| 65 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.43372061 |
| 66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43366636 |
| 67 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.41698032 |
| 68 | Purine metabolism_Homo sapiens_hsa00230 | 0.41592051 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38148066 |
| 70 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.37046315 |
| 71 | DNA replication_Homo sapiens_hsa03030 | 0.36994656 |
| 72 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.36915531 |
| 73 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35082762 |
| 74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.34205990 |
| 75 | Phototransduction_Homo sapiens_hsa04744 | 0.31320647 |
| 76 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.29975056 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.28169974 |
| 78 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.27526184 |
| 79 | Asthma_Homo sapiens_hsa05310 | 0.26207858 |
| 80 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.25348501 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.25111790 |
| 82 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.25051730 |
| 83 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.24855818 |
| 84 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.24452229 |
| 85 | Mismatch repair_Homo sapiens_hsa03430 | 0.24437913 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24249945 |
| 87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.20150244 |
| 88 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.19961974 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.18770273 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18390230 |
| 91 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.15705075 |
| 92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.15664549 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.15575365 |
| 94 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.15278098 |
| 95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.15162993 |
| 96 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.14288091 |
| 97 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.14199979 |
| 98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.13961983 |
| 99 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.13418550 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.12285231 |
| 101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.10294317 |
| 102 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.10004707 |
| 103 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.08513855 |
| 104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.08109324 |
| 105 | GABAergic synapse_Homo sapiens_hsa04727 | 0.08058031 |
| 106 | Morphine addiction_Homo sapiens_hsa05032 | 0.06833136 |
| 107 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.06190676 |
| 108 | Insulin secretion_Homo sapiens_hsa04911 | 0.06134804 |
| 109 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.05939016 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | 0.05263928 |
| 111 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.04761112 |
| 112 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.04489742 |
| 113 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.03418589 |
| 114 | Retinol metabolism_Homo sapiens_hsa00830 | 0.03370095 |
| 115 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.02823725 |
| 116 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.02746385 |
| 117 | Spliceosome_Homo sapiens_hsa03040 | 0.02541083 |
| 118 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.01895790 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.01666747 |
| 120 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.00570556 |
| 121 | Nicotine addiction_Homo sapiens_hsa05033 | 0.00550343 |
| 122 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | -0.0009235 |
| 123 | Homologous recombination_Homo sapiens_hsa03440 | -0.0009079 |
| 124 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | -0.0006583 |

